共 86 条
[1]
Terasawa T(2009)Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin’s lymphoma and diffuse large B-cell lymphoma: a systematic review J Clin Oncol 27 1906-1914
[2]
Lau J(2002)PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin’s disease J Nucl Med 43 1018-1027
[3]
Bardet S(2004)Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma Eur J Nucl Med Mol Imaging 31 22-28
[4]
Kostakoglu L(2006)FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma Blood 107 52-59
[5]
Coleman M(2006)The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin’s disease Haematologica 91 475-481
[6]
Leonard JP(2005)Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma Ann Oncol 16 1160-1168
[7]
Torizuka T(2006)Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin’s disease patients Ann Oncol 17 1296-1300
[8]
Nakamura F(2006)FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease Ann Hematol 85 759-767
[9]
Kanno T(2007)Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma Blood 109 486-491
[10]
Hutchings M(2007)Early interim 2-(18F)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study J Clin Oncol 25 3746-3752